SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-142539
Filing Date
2021-11-22
Accepted
2021-11-22 16:37:29
Documents
4
Period of Report
2021-12-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2133364-1_def14a.htm DEF 14A 705467
2 GRAPHIC lg_petros-4clr.jpg GRAPHIC 26426
3 GRAPHIC tm2133364d1-px_01proxybw.jpg GRAPHIC 1065694
4 GRAPHIC tm2133364d1-px_02proxy4c.jpg GRAPHIC 452632
  Complete submission text file 0001104659-21-142539.txt   2830273
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39752 | Film No.: 211433043
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences